☆ 4.6 Article

Pairwise synthetic cytotoxicity between Paxlovid and 100 frequently prescribed FDA-approved small molecule drugs on liver cells

TOXICOLOGY AND APPLIED PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients

Ronza Najjar-Debbiny et al.

Summary: This study assessed the effectiveness of Paxlovid in high-risk COVID-19 patients in real-world settings. The findings demonstrate that Paxlovid is highly effective in reducing the risk of death and severe COVID-19 in the Omicron era. The study also suggests that Paxlovid may be more effective in older patients, immunosuppressed patients, and patients with underlying neurological or cardiovascular disease. Vaccination status did not significantly impact the effectiveness of Paxlovid.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Review Chemistry, Multidisciplinary

Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19

Can-rong Wu et al.

Summary: The tireless efforts of scientists globally have greatly enhanced our understanding of the biology of coronaviruses, with structural biology playing a key role in uncovering structures and functions of viral proteins and guiding drug and vaccine development. The importance of structure in drug discovery to combat COVID-19 has been highlighted, while attention is needed on the implications of Omicron variants on existing vaccines and antibody therapies.

ACTA PHARMACOLOGICA SINICA (2022)

Add to Collection

Article Multidisciplinary Sciences

Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits

Giacomo G. Rossetti et al.

Summary: A potential M-pro inhibitor for treating SARS-CoV-2 infections has been identified and its efficacy and mode of action have been further characterized.

SCIENTIFIC REPORTS (2022)

Add to Collection

Editorial Material Infectious Diseases

Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19

Francois Girardin et al.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Review Pharmacology & Pharmacy

Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

Catia Marzolini et al.

Summary: The antiviral nirmatrelvir/ritonavir has been authorized for the treatment of high-risk COVID-19 patients. However, due to its potential for drug-drug interactions, caution is needed when prescribing it with other medications metabolized through the same pathway. This review provides recommendations for managing these interactions and presents a list of comedications categorized by their DDI risk.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Summary: Nirmatrelvir plus ritonavir is a medication developed for the treatment and post-exposure prophylaxis of COVID-19. It received authorization in the UK and EU for use in adults at high risk for severe COVID-19. Nirmatrelvir is an inhibitor of SARS-CoV-2 main protease, while ritonavir is a protease inhibitor and CYP3A inhibitor.

DRUGS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Pandemic COVID-19, an update of current status and new therapeutic strategies

Antonio Vitiello et al.

Summary: The global COVID-19 pandemic continues to spread, with a rapid increase in infections in countries, particularly in Europe, likely due to the new Omicron variant of SARS-CoV-2. Mass vaccination efforts are ongoing worldwide. Oral antiviral drugs such as molnupiravir and paxlovid have shown promising results in clinical trials, but their impact on the pandemic and their advantages over other antivirals like remdesivir need further investigation.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Bad news for Paxlovid? Resistance may be coming

Robert F. Service

SCIENCE (2022)

Add to Collection

Article Oncology

The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2 infected children aged 6-14 years: a cohort study

Gangfeng Yan et al.

Summary: This study analyzed the feasibility, safety, and efficacy of Paxlovid Treatment in SARS-CoV-2 infected children aged 6-14 years. The results suggest that Paxlovid is a feasible option for treating children with underlying diseases, but further large-scale studies are needed to confirm its safety and efficacy.

ANNALS OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Medicine, Research & Experimental

Recent advances in small-molecular therapeutics for COVID-19

Lei Zhong et al.

Summary: The COVID-19 pandemic has posed a major global health challenge, leading to efforts in developing antiviral strategies and therapeutic drugs. This comprehensive review focuses on small molecular anti-SARS-CoV-2 agents, discussing approved drugs and important candidates based on different target classifications. The future research and development of anti-SARS-CoV-2 drugs are also examined, offering hope for conquering COVID-19.

PRECISION CLINICAL MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Small molecules in the treatment of COVID-19

Sibei Lei et al.

Summary: This review discusses the current progress in the development of small molecules for the treatment of COVID-19. Various strategies, including computer-aided compound design, natural product discovery, drug repurposing, and combination therapy, have been employed. Some small molecules, such as remdesivir and paxlovid, have shown efficacy against COVID-19 and have been authorized for emergency use in multiple countries. However, novel strategies are still needed due to the epidemiological characteristics and variability of SARS-CoV-2.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Article Food Science & Technology

Tea and its components reduce the production of uric acid by inhibiting xanthine oxidase

Dan Wu et al.

Summary: The study found that different types and fermentation levels of teas have different inhibitory effects on uric acid production, with gallic acid in the main component showing the best effect in inhibiting uric acid. This research provides guidance for choosing teas that are suitable for lowering uric acid levels.

FOOD & NUTRITION RESEARCH (2022)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate

Joanna L. Fox et al.

Summary: Regulated cell death is essential in development and cellular homeostasis. The core FADD:Caspase-8 complex and its regulatory partners, such as the cell death inhibitor c-FLIP, play a critical role in coordinating cell fate. The recruitment of c-FLIPS into this complex inhibits Caspase-8 activity by altering its structure.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Antivirals with common targets against highly pathogenic viruses

Lu Lu et al.

Summary: Throughout history, emerging viruses have constantly appeared and have resulted in millions of human deaths. Climate change and globalization have now created favorable conditions for viral transmission. Thus, the development of effective antivirals, particularly those targeting conserved proteins in multiple unrelated viruses, is urgently needed to combat future emerging and re-emerging viruses.

CELL (2021)

Add to Collection

Article Chemistry, Medicinal

AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings

Jerome Eberhardt et al.

Summary: AutoDock Vina is a widely used open-source program for molecular docking with new features such as support for macrocycles and explicit water molecules. The latest version also includes support for AutoDock4.2 scoring function, simultaneous docking of multiple ligands, and a batch mode for docking a large number of ligands. Python bindings have been implemented to facilitate scripting and workflow development.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Add to Collection

Review Pharmacology & Pharmacy

Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector

Taru Dube et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has paralyzed the world, with advances in viral detection but limited progress in curative therapies. Potential future approaches include repurposed drugs, vaccine candidates, immune-modulators, and nanotechnology-based interventions to combat the deadly virus and facilitate multidrug therapeutics. Therapeutic candidates like remdesivir, dexamethasone, and antibody therapeutics are emerging as promising options in the fight against COVID-19.

ADVANCED THERAPEUTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

Li Runfeng et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Review Cell & Tissue Engineering

Mesenchymal Stem Cell Therapy for COVID-19: Present or Future

Ali Golchin et al.

STEM CELL REVIEWS AND REPORTS (2020)

Add to Collection

Review Microbiology

Drug combinations: a strategy to extend the life of antibiotics in the 21 st century

Mike Tyers et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Add to Collection

Article Chemistry, Medicinal

5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions

Zu-Zhuang Wei et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Review Immunology

Caspase-8: regulating life and death

Bart Tummers et al.

IMMUNOLOGICAL REVIEWS (2017)

Add to Collection

Review Oncology

Combination therapy in combating cancer

Reza Bayat Mokhtari et al.

ONCOTARGET (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Crystal structure of the death effector domains of caspase-8

Chen Shen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Add to Collection

Article Oncology

Radioprotective effects of genistein on HL-7702 cells via the inhibition of apoptosis and DNA damage

Lihua Song et al.

CANCER LETTERS (2015)

Add to Collection

Review Immunology

Functions of caspase 8: The identified and the mysterious

Guy S. Salvesen et al.

SEMINARS IN IMMUNOLOGY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters

James J. P. Stewart

JOURNAL OF MOLECULAR MODELING (2013)

Add to Collection

Article Chemistry, Medicinal

The IC50 Concept Revisited

Gary W. Caldwell et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)

Add to Collection

Review Biotechnology & Applied Microbiology

Combinatorial drug therapy for cancer in the post-genomic era

Bissan Al-Lazikani et al.

NATURE BIOTECHNOLOGY (2012)

Add to Collection

Review Cardiac & Cardiovascular Systems

Managing adverse effects and drug-drug interactions of antiplatelet agents

Arun Kalyanasundaram et al.

NATURE REVIEWS CARDIOLOGY (2011)

Add to Collection

Article Pharmacology & Pharmacy

Guidelines for accurate EC50/IC50 estimation

J. L. Sebaugh

PHARMACEUTICAL STATISTICS (2011)

Add to Collection

Article Chemistry, Multidisciplinary

Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading

Oleg Trott et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)

Add to Collection

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Add to Collection

Review Microbiology

SYSTEMS MICROBIOLOGY - OPINION Drug interactions and the evolution of antibiotic resistance

Pamela J. Yeh et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Add to Collection

Review Microbiology

Antiviral actions of interferons

CE Samuel

CLINICAL MICROBIOLOGY REVIEWS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.